MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Understanding the role of LRRK2 in Indian population

    A. Kishore, M. Sturm, A. Sreelatha, S. Robert, S. Krishnan, M. Banerjee, O. Riess, P. Bauer, R. Kruger, T. Gasser, M. Sharma (Trivandrum, India)

    Objective: Genomic approaches  in Caucasian population show little transferability to other ethnically diverse populations such as Indian population. Understanding the genetic architecture of a disease…
  • 2017 International Congress

    Assessing the response to L-dopa/carbidopa intestinal gel infusion (Deudopa) based on genetic status.

    A. Thaler, A. Hillel, H. Shabtai, N. Giladi, T. Gurevich (Tel-Aviv, Israel)

    Objective: To asses genetic impact on dosage of L-dopa/carbidopa treatment Background: L-dopa/carbidopa intestinal gel infusion (LCIG) is a method of continuous dopaminergic stimulation used in…
  • 2017 International Congress

    Genotype-phenotype correlations in Parkinson disease patients who carry mutations in the GBA gene.

    A. Thaler, T. Gurevich, A. Ezra, M. Kestenbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To assess genotype-phenotype relationship between mild and severe GBA mutation carriers among patients with Parkinson's disease  Background: Mutations in the Glucocerebrocidase gene (GBA) are…
  • 2017 International Congress

    Comparison of the non-motor symptom assessment scale between LRRK2 G2019S positive versus matched control Parkinson disease

    S. Gunzler, S. Mittal, C. Tatsuoka, A. Wilson-Delfosse, S. Chen, J. Mieyal, I.J. Feng, D. Riley (Cleveland, OH, USA)

    Objective: To compare the non-motor symptom assessment scale (NMSS) score between Leucine-rich repeat kinase 2 (LRRK2) mutation carriers with Parkinson disease (PD) and matched controls with…
  • 2017 International Congress

    Patient-derived GBA1-PARK2 double-mutant cellular models to study the effect of GBA1 as a modifier of familial Parkinson’s disease

    Z. Hanss, I. Boussaad, P. Barbuti, S. Goldwurm, R. Krüger (Belvaux, Luxembourg)

    Objective: In this study, we propose to decipher the role of GBA1 as a modifier of familial Parkinson’s disease (PD) using double-mutant patient-derived cellular models…
  • 2017 International Congress

    Caffeinated Drinks, LRRK2 Genotype and PD

    C. Tanner, C. Marras, C. Meng, K. Marder, S. Bressman, R. Saunders-Pullman, R. Alcalay, E. Tolosa, A. Brice, S. Goldman, B. Schuele, A. Lang, S. Goldwurm, G. Riboldazzi, J. Ferreira, C. Klein, D. Berg, K. Brockmann, M. Tazir, J. Aasly, J. Marti-Masso, J. . Marti-Masso, R. Munhoz, C. Rieder, M. San Luciano, G. Mellick, C. Sue, K. Hasegawa, E. Tan, J. Langston, M. LRRK2 Cohort-Consortium (San Francisco, CA, USA)

    Objective: To determine the role of caffeine containing drinks on penetrance in LRRK2-associated PD Background: LRRK2 penetrance is reduced for PD [1]. Environment and/or other…
  • 2017 International Congress

    Parkinson’s disease in untreated Gaucher patients is associated with reduced glucosylsphingosine (Lyso-Gb1) serum levels

    D. Arkadir, T. Dinur, A. Rolfs, A. Zimran (Jerusalem, Israel)

    Objective: To assess the role of glycosphingolipids in increased risk of Parkinson's disease (PD) in patients with Gaucher disease (GD). Background: Patients with GD are…
  • 2017 International Congress

    Interval from onset of Parkinson disease to onset of motor and non-motor complications in Leucine-rich repeat kinase 2 (LRRK2) G2019S positive versus matched PD controls

    S. Gunzler, D. Riley, A. Wilson-Delfosse, S. Chen, J. Mieyal, C. Tatsuoka (Cleveland, OH, USA)

    Objective: To compare the latency between onset of Parkinson disease (PD) symptoms and onset of motor and non-motor complications of PD, between G2019S LRRK2 mutation…
  • 2017 International Congress

    CLOCK rs1801260 polymorphism is associated with suscepibilty of Parkinson’s disease in Chinese population

    F. Lou, X. Luo, M. Li, Y. Ren (Shenyang, China)

    Objective: This study is aimed at evaluating the potential association between the single-nucleotide polymorphism of two functional clock genes (CLOCK gene rs1801260 and PER2 gene…
  • 2017 International Congress

    CLOCK varriant correlates to motor fluctuation and sleep disorders in Chinese patients with Parkinson’s disease

    F. Lou, X. Luo, M. Li, Y. Ren (Shenyang, China)

    Objective: This research is to explore whether there is association between Circadian locomotor output cycle kaput (CLOCK) gene polymorphism and biological rhythm disorders of Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 1291
  • 1292
  • 1293
  • 1294
  • 1295
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley